Delays in breast cancer diagnosis and treatment highlight the need for improved human capital investment in health care ...
Tolion Health AI Appoints Global Health & AI Leader Gregory J. Moore, MD, PhD, to Board of Directors
Tolion Health AI, a digital health company developing artificial intelligence solutions for personalized, predictive, and ...
Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA ...
The appointment expands the current Board of Directors' role to oversee Psilera's clinical development strategy for its next-generation neuroplastogens.
Enrique Velazquez Villarreal, MD, PhD, MPH, MS, reveals how AI is being used to identify early-onset CRC and enhance ...
Jennifer E. Thorne, MD, PhD, is the Cross Family Professor of Ophthalmology at the Wilmer Eye Institute, Johns Hopkins University School of Medicine in Baltimore, Maryland.
Scientists have carried out research in mice that suggests it could be possible to reverse the disease although trials with ...
UCSF researchers have discovered a way to identify deadly lung infections with improved accuracy by pairing AI with a unique ...
MedPage Today on MSN
Five Leaders in One Year: FDA's Drug Center Enters 2026 at a Crossroads
The FDA appointed George Tidmarsh, MD, PhD, to be the nation's top drug official in July. The Center for Drug Evaluation and ...
PA Top Docs has reviewed and approved Dr. David RP Almeida of Erie Retina Research for 2025. ERIE, PA, UNITED STATES, ...
Fannin Partners Awarded $300K Phase I SBIR Grant from the National Eye Institute to Advance First-in-Class Non-VEGF-Targeted Therapeutics for Wet AMD ...
Let’s Innovate Together!’ During my tenure as ASNC president, I will work tirelessly so we can innovate together as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results